ArcelorMittal SAArcelorMittal boosted by Q1 earnings and a share buyback program, with projected earnings growth over 49%.
The Euro Stoxx 50 index has risen 8.2% through June 30, nearly matching the S&P 500's 9.3% gain, driven by a weaker dollar, valuation re-rating, increased EU defense spending, and hawkish rate policy. Three components have delivered index-beating returns over the past 12 months: ArcelorMittal, up more than 90%, with analysts projecting earnings growth over 49% in the next year; Arm Holdings, up over 220% in 2026, with projected earnings growth of approximately 77%; and Novartis, up about 14% in 2026, with expected earnings growth around 11%. ArcelorMittal, a Netherlands-based steel giant, has been boosted by Q1 earnings and a share buyback program, while Arm Holdings, an England-based semiconductor IP company, remains a core AI infrastructure play despite recent volatility. Novartis, a Swiss biopharma firm, offers defensive growth through innovation and dividends, though it faces biosimilar threats and significant R&D spending.
ArcelorMittal SAArcelorMittal boosted by Q1 earnings and a share buyback program, with projected earnings growth over 49%.
Arm Holdings plc American Depositary SharesArm Holdings is described as a core AI infrastructure play, benefiting from sustained AI demand.
Novartis AGNovartis faces biosimilar threats, but also offers defensive growth through innovation and dividends.